|
Bibliography: A Hilary Calvert, Sathyarathnam Ghokul, Abdul Al Azraqi, James Wright, Mike Lind, Nigel Bailey, Martin Highley, Neelam Siddiqui, John Lunec, Debi Sinha, Alan Boddy, Trevor Roberts, and John Fenwick (1999) Carboplatin and paclitaxel, alone and in combination: dose escalation, measurement of renal function, and role of the p53 tumor suppressor gene. Seminars in Oncology 26(1 Suppl 2):90-94. Stephen Bustin and Sina Dorudi (1998) Molecular assessment of tumor stage and disease recurrence using PCR-based assays. Molecular Medicine Today 4(9):389-396 (Review). Michael R Stratton and Richard Wooster (1996) Hereditary predisposition to breast cancer. Current Opinions in Genetics and Development 6:93-97 (Review). Chang EH, Pirollo KF and Bouker KB (2000) Tp53 gene therapy: a key to modulating resistance to anticancer therapies? Molecular Medicine Today 6(9):358-364 (Review). |
Molecular Oncology
|
|
To contact us: |
|
Molecular Oncology |
|
Why we are slow with predictors? |
|
Publication |
